Publication | Closed Access

Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate)

Breast Cancer MetastasisActive Triple ConjugateBreast OncologyOncologyMedicineBreast CancerMulti-stage InhibitionAnti-cancer AgentTumor TargetingCancer TreatmentPharmacologyRadiation Oncology